Please assess the completion status of the following clinical trial:

Trial Title: Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy men 20-35 years old.~2. birth weight \<2500g.~3. Born at gestational week 38- 40 (42).~Exclusion Criteria:~1. Diabetes, insulin-resistance or precursors in first degree relatives or maternal gestational diabetes.~2. Small parents(mother \<160cm and/or father \<170cm).~3. History of abuse of alcohol, medicine og drugs in the mother during pregnancy.~4. Liver of renal failure : s-ALAT \> 2.5 normal upper limit (\>175μM) or s-creatinine \>125 μmol/l.~5. Co-morbidity that after at medical examination is considered to be a problem.~6. BMI\>25.5~7. Smoking that is considered to be an issue as regards completing the study.~8. Treatment with a MAO-inhibitor.~9. Born before gestational week 38.~10. Participation in larger X-ray examinations such CT-scans during the last 12 months.~11. Participation in medical experiments or treatments involving intravenous administration of radioactive substances during the last~12. Ongoing medical treatment that will be considered a issue for completing the study.~13. Allergy towards the substance Escitalopram.~14. Metal parts in the body that contra-indicates MRI.~15. Ongoing medical treatment thrombocyte inhibiting substances such as NSAIDS.~16. Previous gastrointestinal bleeding or gastro-duodenal ulcers.~17. Depression during examination or treatment~16/05-2011: Criterias updated - added 17 and adjusted 6. from BMI \>25 to BMI \>25.5

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- escitalopram (Type: ACTIVE_COMPARATOR): A pill containing Escitalopram
- placebo (Type: PLACEBO_COMPARATOR): a placebo pill

Based on this trial design, predict the completion outcome and termination type (if applicable).